Business Wire

Global Experts and Practitioners Unite to Improve Ocean Health by Tackling Systemic Challenges in Marine Management

28.6.2022 15:02:00 EEST | Business Wire | Press release

Share

Marine protected areas (MPAs) are key tools for reducing threats to biodiversity, safeguarding marine and coastal habitats, building climate solutions, and supporting human needs through sustainable use. The Convention on Biological Diversity’s Global Biodiversity Framework may include an ambitious target of expanding MPA coverage to 30% by 2030. However, less than 3% of marine protected areas are meeting their objectives in the face of accelerating local and global threats.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220628005443/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Dr. Lizzie McLeod, Global Reefs Lead for The Nature Conservancy (Photo: Mary Kay Inc.)

To tackle this challenge, a team of experts is convening at the United Nations Oceans Conference in June 2022 in Lisbon, Portugal in a side event entitled, “Quality Matters: Enhancing Governance, Effective Management and Resilience of Marine Protected Areas for Multiple Co-benefits.” The event includes speakers from the private sector, local marine science agencies, representatives from non-profit organizations, governments, and intergovernmental organizations. Speakers will share how they are spearheading technological innovation and best practices in marine management and will spotlight valuable tools, increase collaboration, knowledge sharing, and uptake of lessons learned. Dr. Lizzie McLeod, Global Reefs Lead for The Nature Conservancy notes, “Strong partnerships including the private sector, governments, NGOs, researchers, and local communities are essential to improving ocean health. Harnessing lessons learned and best practices globally to improve ocean management is a conservation priority including the co-creation of solutions with key partners.”

Building on this event, the United Nations Environment Programme, The Nature Conservancy, and other conservation partners, with support from Mary Kay Inc., are developing a suite of decision support tools for marine managers that improve marine management, support the sustainable financing of marine protected areas, and guide marine habitat restoration building on best practices around the world. By leveraging scientific innovation and new technologies and global best practices, marine managers are better able to tackle major threats facing marine ecosystems around the world. “MPAs are key to ocean health and sustainable development. But they are not always effective without a range of support. Decision support tools that enable improved MPA design and management, knowledge sharing, and collaboration are needed to give marine stakeholders the support they need to better protect the oceans,” said Ole Vestergard, Programme Officer, United Nations Environment Programme.

"Mary Kay is delighted to support TNC, in collaboration with UNEP and other experts from around the world, in an effort to protect our world's most precious assets: oceans," said Deborah Gibbins, Mary Kay’s Chief Operating Officer. "These organizations are on the frontlines of the fight to preserve our waterways, and we're hopeful that with Mary Kay's support, they'll have the tools and resources needed to ensure our oceans are healthy for generations to come.

As governments refine their conservation targets, it is timely to highlight new innovations and technologies that help countries meet global biodiversity and sustainable development goals. New decision tools and foundational science are needed to enhance the capacity of marine planners and managers to better manage marine habitats in the face of climate change and other threats.

About The Nature Conservancy

The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world’s toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters, and oceans at an unprecedented scale, providing food and water sustainably, and helping make cities more sustainable. Working in 79 countries and territories, we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.

About the United Nations Environment Programme (UNEP)

UNEP is the leading global voice on the environment. It provides leadership and encourages partnership in caring for the environment by inspiring, informing, and enabling nations and peoples to improve their quality of life without compromising that of future generations.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

Misty Edgecomb
Communications Director, Protect Oceans, Land and Water
The Nature Conservancy
Las Vegas, Nevada (Pacific time zone)
medgecomb@tnc.org, 484-343-3223 cell
pronouns: she/her, Twitter: @mistyedgecomb

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye